BioSpace News Archive

Technology allows quicker patient discharges from hospital, more frequent patient engagement for appropriate care, less risk of COVID-19 transmission to Nurses and lower costs to Insurance Companies [13-April-2020] ST. LOUIS , April 13, 2020 /PRNewswire/ -- Nurses & Company, Inc., a leading private and locally owned Home Health Care, Hospice Care and Private Servi

Montgomery County, PA, has teamed up with Real Time Medical Systems to provide 24/7 electronic Infectious Disease Surveillance of nursing facilities in the county, who have volunteered to share their data.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of an underwritten public offering of 2,000,000 shares of its common stock,

Lydia McClure, Ph.D., a University of Texas at Austin-educated virologist who serves as Research Bridge Partners’ Vice President of Scientific Partnerships, is an expert on the roles of federal funding and academic research in developing scientific breakthroughs that address critical public needs.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2020 results on Tuesday, May 12, 2020.

The leading medical education group in Brazil - based on number of medical school seats - Afya Limited is committed to the safety and health of its students.

Swedish Orphan Biovitrum AB announces that revenue and EBITA in March are impacted by increases in demand related to the ongoing COVID-19 pandemic.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”), a clinical stage pharmaceutical development company, is pleased to announce that it will be featured on a BioPub webcast today hosted by Dr. KSS at noon EDT. The Company invites interested shareholders, investors, members of the media and the public to listen to the interview.

Kolon TissueGene, Inc. (the “Company”), a leader in advanced cell and gene therapies, announced today that the Clinical Hold issued by the FDA in April 2019 has been lifted effective April 10, 2020, and that the Company can continue with its knee osteoarthritis (OA) phase III clinical trial.

Allied Motion Technologies Inc. (Nasdaq: AMOT) manufactures and delivers critical motion control components, including electronic drives, motors and control assemblies to manufacturers of medical equipment including respirators, ventilators, infusion pumps, medical fluid pumps and other breathing assist equipment required to care for patients with respiratory issues including the coronavirus.